Ads
related to: share
Search results
Insider Selling: EVP & CFO Joel Wine Sells Shares of Matson Inc (MATX)
GuruFocus.com via Yahoo Finance· 1 hour agoThe transaction was executed at a stock price of $120.9, as detailed in the SEC Filing. Following...
Insider Sale: Chief Accounting Officer Mona Chu Sells Shares of Pure Storage Inc (PSTG)
GuruFocus.com via Yahoo Finance· 1 hour agoPure Storage Inc (NYSE:PSTG), a company specializing in data storage technology, including...
Insider Sale: EVP and CFO Barry Hytinen Sells 9,000 Shares of Iron Mountain Inc (IRM)
GuruFocus.com via Yahoo Finance· 1 hour agoOn June 18, 2024, Barry Hytinen, Executive Vice President and Chief Financial Officer of Iron...
AMD Shares Now Top Piper Pick Because of AI Server Chips
Barrons.com· 4 hours agoShares of Advanced Micro Devices traded higher Thursday after a Pipe Sandler analyst issued a...
Insider Sale: President Joshua Isner Sells Shares of Axon Enterprise Inc (AXON)
GuruFocus.com via Yahoo Finance· 1 hour agoPresident Joshua Isner of Axon Enterprise Inc (NASDAQ:AXON) executed a sale of 1,434 shares of the...
Avidity Biosciences executive sells shares worth $385,972 By Investing.com
Investing.com· 1 hour agoIn recent trading activity, Teresa McCarthy, Chief Human Resources Officer at Avidity Biosciences,...
Penn Entertainment Shares Soar On Buyout Report: What Investors Should Know - PENN Entertainment...
Benzinga· 3 hours agoShares of PENN Entertainment PENN traded higher on Thursday with a report linking the company to an...
Insider Selling: SVP and CFO David Weinstock Sells Shares of Essent Group Ltd (ESNT)
GuruFocus.com via Yahoo Finance· 1 hour agoDavid Weinstock, the Senior Vice President and Chief Financial Officer of Essent Group Ltd...
Insider Sale: CFO George Zweier Sells 14,121 Shares of BRT Apartments Corp (BRT)
GuruFocus.com via Yahoo Finance· 1 hour agoOn June 18, 2024, George Zweier, Vice President and Chief Financial Officer of BRT Apartments Corp...
Sarepta Shares Soar 37% Following Expanded Approval for Elevidys
Market Watch· 1 hour agoPublished: June 20, 2024 at 6:50 p.m. ETShareResizeBy Josh BeckermanShares of Sarepta Therapeutics rose 37% to $169.15 in after-hours trading on Thursday after the Food and Drug Administration approved an expanded indication for its Duchenne muscular
